Our focus is to support providers and patients in the US with beneficial medications, and to donate profits to ROW Global, a non-profit organization that improves the education, diagnosis, and treatment available for those living with neurological disorders in under-resourced areas of the world. We currently market Subvenite (lamotrigine tablets, USP) Starter Kits, which are FDA-approved branded generic alternatives to Lamictal (lamotrigine) Starter Kits. Our Starter Kits are designed to simplify the initial dosage regimen for patients initiating lamotrigine therapy.